drugset / Trial / NCT00596596
Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to determine whether prucalopride is safe and effective in patients with chronic idiopathic constipation. Hypothesis: At all doses administered prucalopride given once daily for 4 weeks is safe and well tolerated in patients with chronic idiopathic constipation.
Timeline
- Start
- 1996-09
- Primary completion
- 1997-06
- Completion
- 1997-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prucalopride | Small molecule | 0.5 mg | — |
| Comparator | Prucalopride | Small molecule | 1 mg | — |
| Comparator | Prucalopride | Small molecule | 2 mg | — |
| Comparator | Prucalopride | Small molecule | 4 mg | — |